CD274 and neoplasm: Of note, the clinical response to therapy was found to be independent of the PD-L1 expression on tumor cells, since some patients that were negatively stained for PD-L1 on the tumor surface benefited from PD-1/PD-L1 inhibitor treatment [122,123].